Literature DB >> 17175520

Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.

Gian Paolo Rossi1, Teresa M Seccia, Achille C Pessina.   

Abstract

The prevalence of secondary hypertension can be underestimated if appropriate tests are not performed. The importance of selecting patients with a high pre-test probability of secondary forms of hypertension is first discussed. The laboratory tests currently used for seeking a cause of hypertension are critically reviewed, with emphasis on their operative features and limitations. Strategies to identify primary aldosteronism, the most frequent form of secondary hypertension, and to determine its unilateral or bilateral causes are described. Treatment entails adrenalectomy in unilateral forms, and mineralocorticoid receptor blockade in bilateral forms. Renovascular hypertension is also a common, curable form of hypertension, that should be identified as early as possible to avoid the onset of cardiovascular target organ damage. The tests for its confirmation or exclusion are discussed. The various tests available for the diagnosis of pheochromocytoma, which is much rarer than the above but extremely important to identify, are also described, with emphasis on recent developments in genetic testing. Finally, the tests for diagnosing some rarer monogenic forms and other renal and endocrine causes of arterial hypertension are explored.

Entities:  

Mesh:

Year:  2007        PMID: 17175520     DOI: 10.1080/10408360600931831

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  7 in total

Review 1.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

2.  Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades.

Authors:  Takeshi Namekawa; Takanobu Utsumi; Tomoaki Tanaka; Mayuko Kaga; Hidekazu Nagano; Takashi Kono; Koji Kawamura; Naoto Kamiya; Takashi Imamoto; Hiroyoshi Suzuki; Tomohiko Ichikawa
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

Review 3.  Arterial Hypertension, Aldosterone, and Atrial Fibrillation.

Authors:  Teresa M Seccia; Brasilina Caroccia; Giuseppe Maiolino; Maurizio Cesari; Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2019-11-18       Impact factor: 5.369

Review 4.  Diagnosis and treatment of primary aldosteronism.

Authors:  Gian Paolo D Rossi
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 5.  Prevalence and diagnosis of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

Review 6.  [Update on endocrine hypertension].

Authors:  B Lechner; D Heinrich; S Nölting; A Osswald-Kopp; G Rubinstein; J Sauerbeck; F Beuschlein; M Reincke
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

7.  Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism.

Authors:  François Corbin; Pierre Douville; Marcel Lebel
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.